Medicare Enrolled

Dr. Raymond De La Rosa, M.D.

Endocrinology · Sarasota, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
8383 S TAMIAMI TRL UNIT 115, Sarasota, FL 34238
9418414206
Registered in NPPES since 2006
NPI: 1083667984 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De La Rosa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De La Rosa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De La Rosa

Dr. Raymond De La Rosa is an endocrinology specialist in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. De La Rosa performed 3,411 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. De La Rosa received a total of $60,295 from 40 pharmaceutical and/or device companies across 369 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De La Rosa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 19% volume in FL $60,295 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,411
Medicare services
Top 19% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,080 $19 $46
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
542 $90 $264
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
468 $8 $17
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
302 $10 $21
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
241 $16 $34
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
209 $9 $19
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
116 $9 $18
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
74 $29 $59
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
71 $13 $27
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $113 $347
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
60 $6 $12
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
60 $5 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
43 $127 $370
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
23 $27 $71
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
22 $11 $31
Total cortisol level test
A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands.
17 $16 $33
New patient office visit, complex (60-74 min) 12 $144 $458
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$60,295
Total received (2018-2024)
Avg $8,614/year across 7 years
Top 9% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
369
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,260
2023
$2,143
2022
$675
2021
$649
2020
$958
2019
$14,404
2018
$40,206

Payments by company (2024)

Amgen Inc.
$309
Novo Nordisk Inc
$238
SANOFI-AVENTIS U.S. LLC
$173
Radius Health, Inc.
$135
Abbott Laboratories
$100
AstraZeneca Pharmaceuticals LP
$66
Kyowa Kirin, Inc.
$63
Novartis Pharmaceuticals Corporation
$55
UCB, Inc.
$25
Aurinia Pharma U.S., Inc.
$22
PFIZER INC.
$20
Lilly USA, LLC
$20
ABBVIE INC.
$19
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$44,213
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,594
SANOFI-AVENTIS U.S. LLC
$4,766
Lilly USA, LLC
$1,080
Abbott Laboratories
$809
AstraZeneca Pharmaceuticals LP
$656
Amgen Inc.
$648
Radius Health, Inc.
$365
Esperion Therapeutics, Inc.
$254
Bayer Healthcare Pharmaceuticals Inc.
$205
Merck Sharp & Dohme Corporation
$188
Bayer HealthCare Pharmaceuticals Inc.
$184
Dexcom, Inc.
$161
Janssen Pharmaceuticals, Inc
$118
Kowa Pharmaceuticals America, Inc.
$109
Novartis Pharmaceuticals Corporation
$94
AbbVie Inc.
$80
Corcept Therapeutics
$79
Amarin Pharma Inc.
$74
ABBVIE INC.
$65
Tandem Diabetes Care, Inc.
$63
Kyowa Kirin, Inc.
$63
Boston Scientific Corporation
$55
Insulet Corporation
$51
Genentech USA, Inc.
$43
Xeris Pharmaceuticals, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$28
UCB, Inc.
$25
Aurinia Pharma U.S., Inc.
$22
Exact Sciences Corporation
$22
PFIZER INC.
$20
Strongbridge US INC.
$17
Eisai Inc.
$16
Orexigen Therapeutics, Inc.
$15
Biohaven Pharmaceutical Holding Company Ltd.
$15
IBSA Pharma Inc.
$15
Mannkind Corporation
$15
Shire North American Group Inc
$12
Scilex Pharmaceuticals Inc.
$12
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 90.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · Aimovig · BREZTRI · BYDUREON · Bimzelx · CONTRAVE · CREON · Cologuard Collection Kit · DEXCOM G7 GSS (161) · Dayvigo · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE PFS · HUMULIN · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LUPKYNIS · Licart · Livalo · MACRILEN · MOUNJARO · NATPARA · NEXLETOL · NEXLIZET · NURTEC ODT · Omnipod · Otezla · Ozempic · PAXLOVID · QULIPTA · Repatha · Rybelsus · SOLIQUA · SYNTHROID · Saxenda · TALTZ · TEPEZZA · TOUJEO · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · VRAYLAR · Vascepa · Victoza · WATCHMAN Access System · Wegovy · XARELTO · Xofluza · Xultophy 100/3.6 · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Sarasota?
Compare endocrinologists in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
24
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. De La Rosa is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. De La Rosa experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. De La Rosa performed 1,080 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. De La Rosa receive payments from pharmaceutical companies?
Yes. Dr. De La Rosa received a total of $60,295 from 40 companies across 369 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De La Rosa's costs compare to other endocrinologists in Sarasota?
Dr. De La Rosa's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De La Rosa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →